These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 27992665)

  • 1. Naloxone Antagonizes Soman-induced Central Respiratory Depression in Rats.
    Škrbić R; Stojiljković MP; Ćetković SS; Dobrić S; Jeremić D; Vulović M
    Basic Clin Pharmacol Toxicol; 2017 Jun; 120(6):615-620. PubMed ID: 27992665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soman and sarin induce a long-lasting naloxone-reversible analgesia in mice.
    Clement JG; Copeman HT
    Life Sci; 1984 Apr; 34(15):1415-22. PubMed ID: 6708739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cardiovascular and respiratory effects of various doses of soman in guinea-pigs: efficacy of atropine treatment.
    Worek F; Szinicz L
    Arch Int Pharmacodyn Ther; 1993; 325():96-112. PubMed ID: 8110034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors.
    Santos MD; Pereira EF; Aracava Y; Castro NG; Fawcett WP; Randall WR; Albuquerque EX
    J Pharmacol Exp Ther; 2003 Jan; 304(1):254-65. PubMed ID: 12490599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptor dysfunction induced by exposure to low levels of soman vapor.
    Dabisch PA; Horsmon MS; Muse WT; Mioduszewski RJ; Thomson S
    Toxicol Sci; 2007 Nov; 100(1):281-9. PubMed ID: 17693423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine.
    Buccafusco JJ; Graham JH; Aronstam RS
    Pharmacol Biochem Behav; 1988 Feb; 29(2):309-13. PubMed ID: 3362926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic effects of NBQX against soman-induced seizures.
    Lallement G; Pernot-Marino I; Foquin-Tarricone A; Baubichon D; Piras A; Blanchet G; Carpentier P
    Neuroreport; 1994 Jan; 5(4):425-8. PubMed ID: 8003667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device for quantitating tremor activity in mice: antitremor activity of atropine versus soman- and oxotremorine-induced tremors.
    Clement JG; Dyck WR
    J Pharmacol Methods; 1989 Aug; 22(1):25-36. PubMed ID: 2770314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of atropine and oxotremorine on neuromuscular transmission at the rat hemidiaphragm preparation.
    Wali FA; Suer AH; McAteer EJ; Dark CH
    Arch Int Pharmacodyn Ther; 1987 Jul; 288(1):120-35. PubMed ID: 2821939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of atropine pre- and post-treatment in ganglion neurons exposed to soman.
    Heppner TJ; Fiekers JF
    Brain Res Bull; 1992 Jun; 28(6):849-52. PubMed ID: 1638413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity to antimuscarinic agents following brief exposure to Soman and Sarin.
    Fernando JC; Hoskins B; Ho IK
    J Toxicol Environ Health; 1986; 18(1):103-9. PubMed ID: 3701876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse.
    Buccafusco JJ; Aronstam RS
    J Pharmacol Exp Ther; 1986 Oct; 239(1):43-7. PubMed ID: 3761196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a single dose of an acetylcholinesterase inhibitor on oxotremorine- and nicotine-induced hypothermia in mice.
    Clement JG
    Pharmacol Biochem Behav; 1991 Aug; 39(4):929-34. PubMed ID: 1763113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
    Vargas HM; Ringdahl B
    J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REM sleep pathways and anticholinesterase intoxication: a mechanism for nerve agent-induced, central respiratory failure.
    Kok A
    Med Hypotheses; 1993 Aug; 41(2):141-9. PubMed ID: 8231994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atropine upon the cerebrovascular system during soman-induced respiratory depression.
    Lipp JA; Dola TJ
    Arch Int Pharmacodyn Ther; 1978 Oct; 235(2):211-8. PubMed ID: 104676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of various respiratory dynamics parameters following acute inhalational exposure to soman vapor in conscious rats.
    Perkins MW; Wong B; Rodriguez A; Devorak J; Sciuto AM
    Inhal Toxicol; 2015; 27(9):432-9. PubMed ID: 26207672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against soman-induced neuropathology and respiratory failure: a comparison of the efficacy of diazepam and avizafone in guinea pig.
    Taysse L; Daulon S; Delamanche S; Bellier B; Breton P
    Toxicology; 2006 Aug; 225(1):25-35. PubMed ID: 16784801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats.
    Kassa J; Jun D; Kuca K; Bajgar J
    Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):328-32. PubMed ID: 17910616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing nerve agent treatment efficacy by P-glycoprotein inhibition.
    Joosen MJA; Vester SM; Hamelink J; Klaassen SD; van den Berg RM
    Chem Biol Interact; 2016 Nov; 259(Pt B):115-121. PubMed ID: 27287416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.